<< | < | Showing 1 - 10 of 27 | > | >>

VSI presents scientific findings at FIGO World Congress in South Africa
Venture Strategies Innovations’ (VSI) medical and program experts presented scientific findings to the largest global gathering of obstetricians and gynecologists as a part of the 19th World Congress of Gynecology and Obstetrics in Cape Town, South Africa October 4-9, 2009.

VSI achieves two registrations of misoprostol for treatment of incomplete abortion and miscarriage
Venture Strategies Innovations (VSI), in collaboration with our manufacturer and local distributor partners, has achieved registration of misoprostol for treatment of incomplete abortion and miscarriage in Mozambique and Kenya.

Uganda launches national misoprostol program to prevent excessive bleeding after childbirth
On Friday, June 26, 2009, the Ministry of Health of Uganda, with support from Venture Strategies Innovations and PACE, launched its first national program introducing the life-saving drug misoprostol for prevention and treatment of excessive bleeding after childbirth—a condition that takes the lives of over 5,000 Ugandan mothers each year.

Madagascar launches its first misoprostol study to reduce maternal deaths from postpartum hemorrhage and incomplete abortion
On Friday, June 12, 2009, the Ministry of Health and Family Planning of Madagascar and Marie Stopes Madagascar, with technical and financial support from Venture Strategies Innovations, launched “Saving Malagasy Women’s Lives with Misoprostol,” a pilot study introducing misoprostol to reduce maternal deaths in the island nation.

Melodie Holden appointed President of Venture Strategies Innovations
On Tuesday, June 16, 2009, the board of directors of nonprofit organization Venture Strategies Innovations (VSI) voted Melodie Holden as the new President of VSI.

Misoprostol for safe delivery featured in special Mother's Day section in New York Times
On Sunday, May 10, 2009, the New York Times featured an editorial about the role of misoprostol in safe delivery in a special section devoted to the question: "What Do You Give the Developing World for Mother's Day? The piece, written by Venture Strategies' Communications Manager Amy Grossman, highlights misoprostol as an inexpensive tablet effective at preventing maternal deaths from postpartum hemorrhage in developing countries.

New report cites increase in global availability and sales of misoprostol
New report on global availability and sales of misoprostol highlights increased access to and sales of misoprostol in Venture Strategies' program regions.

Strong community focus key to success in ongoing misoprostol project in Northern Nigeria
In 2009, Venture Strategies and the Bixby Center at UC Berkeley began implementation of a community-based project in Kaduna state in conjunction with Ahmadu Bello University in Zaria. The project engages traditional midwives and birth attendants to administer misoprostol for prevention of postpartum hemorrhage and will provide empirical evidence to inform policy makers on community availability of misoprostol for home births.

Venture Strategies attends African First Ladies' Health Summit
The wives of presidents and prime ministers of 15 African countries convened for the first ever African First Ladies’ Health Summit on Monday, April 20 and Tuesday, April 21, 2009 in Los Angeles, California to present their efforts to improve health in their countries and build collaborative partnerships with organizations with similar goals.  Venture Strategies participated in this noteworthy and exciting event focusing on the First Ladies’ work in the realms of HIV/AIDS, reproductive, maternal and child health, and girls’ education.

Venture Strategies' misoprostol work featured at regional conference of African obstetricians and gynecologists
Venture Strategies for Health and Development sponsored a plenary session at the 8th International Scientific Conference of the East, Central and Southern African Association of Obstetrical and Gynaecological Societies in Mombasa, Kenya on February 19, 2009.  Hosted by the Kenya Obstetrical and Gynaecological Society, more than 350 members of professional associations from nine African countries, Canada and Chile attended this year’s conference.


<< | < | Showing 1 - 10 of 27 | > | >>
YOU CAN:
tell a friend about Venture Strategies
join our list today to receive periodic updates on what's new at Venture Strategies